BridgeMD
Compares treatment options for Revisional Bariatric Surgery
Official title Comparing Revisional Laparoscopic Roux-en-Y Gastric Bypass Versus Ringed Revisional Roux-en-Y Gastric Bypass After Laparoscopic Sleeve Gastrectomy
ClinicalTrials.gov ID: NCT07436013
What this study is testing
- What it's testing
- Obesity remains a major global health challenge, with rising prevalence and significant metabolic, cardiovascular, and gastrointestinal comorbidities. Laparoscopic sleeve gastrectomy (LSG) has emerged as the most widely performed bariatric procedure due to its technical simplicity and satisfactory short- to mid-term results.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults aged 18-65 years.
- Patients who experienced recurrent weight gain, suboptimal weight loss, or both within 12-24 months or more following sleeve gastrectomy.
- Eligible and fit for bariatric surgery.
- Willing to provide informed consent and adhere to follow-up.
You likely can't join if
- Severe psychiatric disorders or uncontrolled substance abuse.
- Pregnancy or planned pregnancy within 2 years post-surgery.
- Chronic steroid use or immunosuppressive therapy.
- Active malignancy or history of gastrointestinal cancer.
- Severe cardiac or pulmonary disease precluding surgery.
- Uncontrolled endocrine disorders (other than T2DM).
See the full eligibility criteria
- Adults aged 18-65 years.
- Patients who experienced recurrent weight gain, suboptimal weight loss, or both within 12-24 months or more following sleeve gastrectomy.
- Eligible and fit for bariatric surgery.
- Willing to provide informed consent and adhere to follow-up.
- Severe psychiatric disorders or uncontrolled substance abuse.
- Pregnancy or planned pregnancy within 2 years post-surgery.
- Chronic steroid use or immunosuppressive therapy.
- Active malignancy or history of gastrointestinal cancer.
- Severe cardiac or pulmonary disease precluding surgery.
- Uncontrolled endocrine disorders (other than T2DM).
- Inability to comply with follow-up or protocol requirements.
The study team makes the final eligibility decision.
Where it's taking place
- Alexandria, Alexandria Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alexandria, Alexandria Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.